Skip to content
OpenCapital
Get started

US Physical Therapy USPH Notes Receivable Related To Sale Of Non Controlling Interest Temporary Equity

Other financials

Income statement

See full
Revenue$198.3M+7.9%
Gross profit$32.8M+5.4%
Operating income$12.5M-36.5%
Net income$5.0M-49.1%
EPS (diluted)-$0.12-115%

Balance sheet

See full
Cash & equivalents$28.4M-27.4%
Total debt$169.4M+12.6%
Total equity$469.0M-5.7%
Total assets$1.2B+5.3%

Cash flow

See full
Operating cash flow$3.8M+181%
CapEx$5.4M+108%
Free cash flow-$1.6M+78.4%

Valuation

See full
Market cap$1.01B-10.6%
Enterprise value$1.15B-7.2%
P/E29×-4.8×
P/S1.3×-0.3×

Profitability

See full
Gross margin19%+0.9pp
Operating margin10%+0.3pp
Net margin4.4%-0.4pp
FCF margin8.4%+0.4pp

Returns & leverage

See full
Return on equity7.2%+0.4pp
Debt / equity0.4×+0.1×
Current ratio1.2×0.0×

Where this comes from

Reported directly by US Physical Therapy in its filing.

Tagged under the XBRL concept usph:NotesReceivableRelatedToSaleOfNonControllingInterestTemporaryEquity.

The official record: US Physical Therapy’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about US Physical Therapy's notes receivable related to sale of non controlling interest temporary equity.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is US Physical Therapy's notes receivable related to sale of non controlling interest temporary equity?
US Physical Therapy (USPH) reported notes receivable related to sale of non controlling interest temporary equity of $3.65M in Q1 2026.
How has US Physical Therapy's notes receivable related to sale of non controlling interest temporary equity changed year-over-year?
US Physical Therapy's notes receivable related to sale of non controlling interest temporary equity increased by 464.9% year-over-year, from $646K to $3.65M.